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Uptake of I PM [‘H]L-glutamate by cultured 3T3 tibroblasts was strongly dcpcndent on cxtraccllular Na’: it was reduced by elevated conecntrations 
of K’ (60 mM) but it was not influenced by variations in the concentration of Ca” (O-9.6 mM). D- and L-Asparate, D and r-lreo-_3-hydroxyas- 
partate DL-threo-3-met~y~aspartatc and a few other glutamate derivatives and analogua inhibited the uptake but several c!ose analogues of 
t-glutamate (including o-glutamate) had no effect, implying that the uptake system is highly structurally selective. The recently identified inhibitor 
ofglutamatc uptakein synaptosomal preparations. L-rrans-pyrrolidinc-2&dica~boxylatc, wasalsoamongthe inhibitors. Apparent h;,ofthcuptake 
was found to be cl0 pM. The present observations indicate that Na’-dependent ‘high-affinity’ uptake of r-glutamate may appear in structures 
which are apparently unrelated to glutamatcrgic synaptic transmission in thz CNS. 
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I. INTRODUCTION 
t--Glutamate has been shown to be accumulated by 
‘high-affinity’ (apparent K, c 50 PM), Na+-dependent 
uptake systems in rat brain sy- -, %somes [l]. ‘mini- 
slices’ of rat cerebral cortex 121, glia-enriched fractions 
of rabbit cerebral homogenates [3], cat [4] and rat IS] 
spinal cord slices (but see also {6]), human brain 
tumours [7], dorsal spinal ganglia [X], preparations from 
human brain ([9] for a review see [lo]), cell lines cultured 
from, respectively, glioma (C6) [3,1 I]. mouse neuro- 
blastoma (C 1300) [12] and neonatal Syrian hamster glial 
cells (NN) [13],.as well as by primary cultures of both 
glia and neurons from newborn and embryonic mouse 
and rat brain [14-171. The principal common aim of 
virtually all of those studies was to investigate the rcla- 
tionship of high affinity uptake of L-glutamate to the 
glutamategic synaptic transmission in the nervous tis- 
sue. In contrast, the experiments discussed in the pres- 
ent article were conducted in order to examine whcthcr 
a similar high-affinity uptake system of r-glutamate can 
be expressed in cells other than those originating from 
the central nervous tissue, for example in cultured fi- 
broblasts of embryonic origin. 
2. MATERIALS AND METHODS 
Cell line. 3T3. was selcctcri as a readily avnilab!e model of em- 
bryonic fibroblasts in culture. 1%~ cells wcrc grown in 35 mm culture 
dishes (Coming, Sclhy Anax and Disposable Products. Sydncyl in 
bicarbonate-burnred Dulbecco’s modified Eagle’s medium (DMEM, 
Sigma)contuining u-glucoscat 4.5 g/l (25 mM) and supplcmcnted with 
cbrrl*.rpun&*nrc* a&&s.%: V.J. Balcar. Dcp~tn~nt of Anatomy. An- 
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10% of heat-inactivated (55°C for 60 min) foetal bovine strum (FBS. 
Cytosystems). The dishes wcrc kept at 37°C in a humidified atm6 
sphere containing 5% CO,. Alter 4-6 days, when the cells formed 
confluent monolayers. they were used for experiments. 
A previously described technique was used to study uptake of [“H]L- 
glutamate rl3.171. The culture medium was rzplaeed with 2 m! of 
incubation medium f125 mM NaCi, 4.5 mM KCI. 1.2 mM CaCl, 1.2 
mM MgCI,) butTered (pH 7.4) by IO mM sodium phosphate or, when 
higher coneeatrations of CaCl, or choline chloride wene present. by 
25 mM Tricinc-Na’ (pH 7.4). Also, 1 g of D-glucoscfl (5.5 mM) was 
added to the medium, 
The cells were pre-incubated, in the prcscncc of a potential inhibitor 
when necessary. at 25°C in a shaking water bath (about*70 strokcj; 
min. dishes held in a custom-made rack). (‘HlL-Glutamatc at a re- 
quired concentration and specific activily was then added and the 
incubation continued for as long as necessary in each particular cxper- 
imcnt (usually 5 min). At the end of the incubation. the medium was 
removed by suction end the cells were washed twice with 2 ml ~lTrcsh 
[3H]L-glutamate-free medium tat room temperature 17-22°C). ihc 
cells wcrc cutractcd with I ml of 0.25 mM NaOH overnight and 0.5 
ml aliquots were taken for the dctcrminalion of radioactivity h) 
scintillation counting using 4.5 ml of Opti-C;or (Canberra Packard) 
in alastic minivials and Packard ZQU0C scintillation counter. ‘PI -c- . ~-- 
maindcr of the ,‘kalinc extract was used for pro&i &rrraLn ,I P;. 
Kinetic constants were calculated usig Multifit II program 
(Cambridge. UK). 
Fossiblc metabolic conversion of [‘H]L-glutamate taken up by the 
cells was investigated as described in an earlier study 1131. except that 
a high pcrformanccautoradiogmphic film(Hyperfilm-‘H. Amcrsham. 
UK). rather than a scanner. was used to visualix the distribution of 
radioactivity on the thin layer chromatogram. Also. following the 
autoradiography, samples of silieagccl wcrc collcctcd iron? the pbth 
(T-6145. Sigma, St. Louis. MO. USA) and assayed for radioactivity 
by scintillation counting, The cxpcriments indieated that at Ir;rst SO% 
ofthc reeovcred tritiun was present in the form of[‘H]L-glutamate (R, 
- 0.42 in jr-batanoliacetic acid/water. 4:1: I by vol.). Thcrc was no 
evidence. such as additional spots or peaks. of imy ‘H-labelled mela- 
bolites. 
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Fig 1. Suucumd formulae of L-aspamte, &utamate, +&ne sul- 
p?~&~te, r-homocystcate, dihydxWinatc and L-rrans-pyrrolidine-2.4- 
diirboxylate. The structures are repnscuted in fully ionized forms. 
Aspartatc. ~-cysteiac sulphinatc and L-tr~~-pyrrolidino2.~i~r- 
boxylatc inhibital L-dutamate uptake. L-homocystcate was a weak 
inhibitor and dihvdrolcainatc was inactive. 
(Table II). Among them, L- and D-aspartate, together 
with their Isubstituted derivatives+ three3-hydruxyas- 
partate and t/zret+3-niethyl aspartatc, as well as ~-cys- 
teinesulphinate and Lcysteate (i.e. analogues closer to 
aspartate than to glutamate in terms of the distance 
between the two negatively charged groups) inhibited 
strongly (2 50%) at 250pM and in some cases at 25 pcLhf 
concentration. In contrast. r-homocysteate, which is 
only one carbon atom longer than L_CYW. ..te, was a 
:clativcly weak inhibitor even at 241i PM. Significantly, 
although D-aspartate was an inhibitor, albeit weaker 
than L-aspartate, D-glutrmate had no effect. cvcn at 250 
PM concentration. Among the other types of structural 
alterations only the esterification or hydroxamation of
the 4 or sCarboxy in aspartate or glutamate produced, 
in some cases, compounds capable of interacting with 
the uptake system. However~ their inhibitom potency 
also depended on the configuration of the 2-carbon (L- 
enantiomer stronger than o-enantiomer) and on the 
length of the carbon-atom chain (SC a weaker inhibitor 
than 40. Thus. L-aspartate4hydroxamatc wan a more 
potent inhibitor than the corresponding o-enantiomer 
and the ~-glutamate derivatives (~-glutamate-5. 
benzylestcr and t_-glutamate&hydroxamate) were 
=Wkef inhibitors than the corresponding L-spartatc 
dcrivativa KI’rblc It). N-Substitution. 2-subtitution. 
I~ragcf Grbon a;om chain (643. a3 ucll a5 additional 
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conformational restrictions. uch as those in 3-((RS)-2- 
carboxypiperatin4yl)-propyl-I-phosphonate (CPP, 
antagonist. at N-methyl+aspartate receptors in the 
CNS [ZCj), kainate (active on another subclass of exci- 
tatory glutamate receptors [20]) and dihydrokainate, 
Table II 
Inhibition of the uptake of 1 MM [‘H]L-glutamate iu 3T3 cells 
Compound Inhibitor concen- % inhibition 
tration &M) 
L-Glutamate 
u-Glutamate 
L-Aspartatc 
D-Aspartatc 
L-Cystcinesulphinatc 
L-rlrrro-3-Hydroxyaspartatc 
r>-rhrro-3-Hydroxyaspartatc 
L-rrutfs-Pyrrolidinc-2,4_dicarboxylatc 
L-Cystcatc 
3-Aminoglutaratc 
L-Homocystcatc 
L-Aspartat&hydroxamatc 
a-Aspartatc4hydroxamatc 
L-Aspartatc4-bcnzylcstcr 
L-Aspartatc4-mctbylcstcr 
L-Glutamate-S-hydroxamatc 
L-Glutamate-5-bcnzylcstct 
m.-3-(J’-chlorophcny))-g)utamatc** 
5 36 t 2 
25 50 L 3 
2.50 84 c I 
250 
25 54nq.2 
250 66 + 3 
25 27 -+ 7 
250 53 + 6 
25 40 + 2 
250 55 + 7 
250 66 2 5 
25 65 r 5 
250 76 + 2 
25 27 f 3 
250 58 f 4 
25 42 ” 4 
250 71 c3 
SO ” 79 52 + 9 I 
250 25 * A 
250 60 a 5 
250 n.s. 
250 59 + 6 
250 62 f 5 
500 n.s. 
250 18 f 4 
500 29 & 8 
* 37 + 7 
Tcstcd compounds wcrc present in the medium during the 5 min 
prc-incubation. I PM [‘H]L-glutamate (usually 250 flCi&mol) was 
then added and the incubation continued for another 5 min. Zero-time 
(-5- IO s) incubations wcrc used as blanks uccounting for IO 15% of 
the total. The resulta arc cxprc~scd as % inhibition (darcasc in uptake 
ascompared to an inhibitor-frcccontrol) + SD. (#I= 4). Ifthcprcsuncu 
of a compound in the incubation medium rcsultcd in less than 17% 
dilkrcncc from controls (and P p 0.0 2% by SWlcnt’s I-ICSI) the inhibi- 
tion was marked ns. (not signiticanr) or the compound was listed as 
inacrivc. Typical contra) values WCIU about 20 pmol/mg protein/min 
(not corrc~~tcd for diffusion which would account for abou: 14% of 
uptake at I FM substmtc concentration. cf. Table I) and although 
constant within a biltch of C&S. could vary considerably from batch 
to batch from aa low as 9 to as high as 40 pmollmg protoin/min. 
lnactivc as 250 PM: ol-l-Aminoadipatc. 3-aminosdipatc. f-((/W-2- 
carhoxypipruzin4-yl)-propyl-I-phosphonatc (Cl’)‘)“. chcliJunic 
rrcid”, 6-cyano-7-nitroquinoxalinc-2,3-dionc (CNQX. FGO65))“. Ji. 
hydrokainatc. kainatc, L-mcthioninc sulphoxido. aI.-mcthionittc*ol,- 
rulphoximinc. 2-muthyl.l,L-ssprtrtc. ?-ln~thyl-lw-slut;lmatLI and h’- 
muthyl-u-aupartatc (NMDAJ. 
produced inactive compounds (Tabi: II). However, the 
conformationalty restricted glutamate analogue, L- 
rrans-pyrrolidine-2,4-dicarboxy~re, was an inhibitor of 
L-glutamate uptake (Table II). Several other corn- 
pounds related to L-glutamate, such as $cyano_T-nitro_ 
quinoxaline-2,3dione (CNQX, active at non-NMDA 
receptors in the CNS [20]) or chetidonic acid and LX- 
methionine-or-sulphoximine (i hibitors of enzymes in- 
volved in the metabolism of L-glutamate [2122]) were 
inactive. 
Uptake of 1 (uM [3H]L-glutamate was virtually abol- 
ished when the concentration of Na’ was reduced to 5 
mM (Fig. 2a). However, neither the absence (in the 
phosphate-buffered medium, not shown) nor an &fold 
increase in the concentration of Ca?’ had any effii. 
although an increase in the K’ concentration to60 mM 
reduced the uptake significantly (Fig. 2a). This reduc- 
tion was even higher when the increase inK’ concentra- 
tion was offset by the corresponding decrease in the 
concentration of Na’ to maintain constant osmolatity 
(Fig. 2~)~ Replacement of Na’ by choline or Li’ rather 
than by K’ resulted in a smaller decrease in the uptake 
(Fig. 2c. replacement by Li’ not shown). When the con- 
centration of 100 NM [3H]L-glutamate was used, only 
the reduction of Na” concentration to 5 mM resulted in 
a decrease of uptake, which was, moreover. rather 
modest when compared with that observed at 1 NM 
[“HJt-glutamate (Fig. 2b). 
4. DISCUSSION 
The high-affmity uptake of L-glutamate has not yet 
been exlensively studied in cultured fibrob!.asts al- 
though there is at least one report in the literature of 
L-glutamate uptake in 3T3 cells which is of ‘high affin- 
ity’ (K,, = 16 pM!. This uptake system was described as 
moderately Na+-dependent, ot affected by elevated 
concentration of I<+ but sensitive to the absence of Ca” 
[I I]. thus perhaps indicating that it might have been 
similar to the Ca”/Cl--depcn&nt glutamate uptake oh- 
served in ~1;“’ cells and brain homogc,larcj [Z -L,j. 
However, a more recent attempt o study the high-affin- 
ity component of L-glutamate uptake in 3T3 fibrobiasts 
was unsuccessful [28J. These contradictory observations 
could be explained by the variations in the potency of 
L-glutamate uptake (sometimes encountered in the pm- 
cnt expcrimcnts. too, cf. Table II, legend) among bat- 
chcs of 3T3 cells. 
The strong Nn’dcpendcncc. insensitivity to the 
variations in Ca”‘-conccntration and inhibition by 3- 
substituted glutamntc analogucs dcmonstratc that the 
high-affinity uptake for glutamate in 3T3 cclhi observed 
under the prcscnt cxocrimcntal conditions; isclearly dif- 
l&cat from the CG’- and Cl’“-dcpendcnt glutamate 
uptalic 12%“271. Rrrthcr. ‘+c kinetic propcrtim and ionic 
rLyuircmcnts would scxm to rclatc II IO the CILM of high 
&‘nity No’-(jep&cnt uptuke systems USUid_V dis- 
cuss+ within the context of synaptic events in the cen- 
tral nervous tissue 129.301. 
It has been proposed that the high-affimty uptake is 
the chief means of limiting the excitatory action of L- 
glutamate released from glutamaWrgic synaptic termi- 
nals [31]. High&T&y uptake of L-glutamate has even 
been used as a marker for glutamatergic synapses. pre- 
sumably on the assumption that it is localized within the 
glutamatergic terminals or adjacent glial ~~11s [32-381, 
although this approach has recently been criticized [24]. 
In fact. several studies using synaptosomes and brain 
slices have demonstrated regional variations in the 
brain [39A;] and thus provided an indication that glu- 
tamate Uptake may not be a homogeneous process 
linked to a single aspect of the neuronal function, but 
rather a family of distinct, though mutually similar, 
uptake systems. This view has been supported by data 
obtained in cultured cells which have, furthermore. sug- 
gested that, according to their structural requirements, 
glutamate-specific, Na+-dependent high-affinity uptake 
systems could be broadly classified into two groups. 
Those found in cultured neuroblastoma 112,421 do not 
take up aspartate very efficiently but they interact with 
the longer carbon atom-chain analogue of L- glutamate, 
2-aminoadipate. In contrast, t-glutamate uptake in cul- 
tured glial ceils readily interacts with aspartate and is 
only very weakly, or not at all, afffected by 2-aminoadi- 
pate [13.42]. Other differences. along the same lines. 
have also been reported [43]. 
The high affinity uptake of r-glutamate discussed in 
the present communication is, using the above criteria, 
similar to the ‘glial’ Na’-dependent high-affinity glu- 
tamate uptake system. It is strongly inhibited by aspar- 
tate, especially by the L-enantiomer. and it is insensitive 
to 2-aminoadipate. This is paralleicd by ;hc action of 
sulphur-containing aspartatc/glutamate analogucs. L- 
cysbxac (shorter analogue. stronger inhibitor) snd L- 
homocystcate (longer analoguc. weaker inhibitor). The 
same principle holds for 1,;droxamatcs and bcnzy’ cc- 
ters of L-aspartate and L-glutamate. It would seem. 
thcreforc. that !hc binding site on the put:\tivc carrier 
interacts preferentially with a folded (shorter). rather 
than cxtcnded ilonger) conformation of L-glutamate. 
but this simple intcrprctation is not cntircly consistent 
with the stronl; inhibition s:lown by the recently idcnti- 
tied specific inhibitor of synaptosotnal uptake of L-glu- 
ramatc. L-rruns-pyrrolidinc-2.4-&carboxylate WI 
which maintains. through a conformationally rcstric- 
ting prcsencc of a rigid pyrrolidine ring within its struc- 
ture_ a distance bctwecn the two negatively charged 
(wrboxyl) groups closer to that in the extended. rather 
than folded. conformation of glutamate (Fig. I ). In ad- 
dition. dihydrokainatc 1451, in which a non-bonded in- 
tcraction bet.veen 4-isopropyl and 3-carbuxymcthyl 
ucru!d MZXZIF~ ICI lbruu the gl~ramatc-hkr pat? uf’ the mc.~l- 
e~ulc au;ry f’rvrn the cx;ended cunlirrmatron. \V;IS in;rc- 
trvc. T’hc CULT obursvstion WUIJ bc cqArnr4 by an 
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analagy bctwccn the nitrogen atom within the pyrroli- 
dine ring of dihydrokainate and the N-substitution 
which makes N-methyl- o-asparate inactive as a gluta- 
mate uptake inhibitor. However, this explanation disre- 
gards the fact that the same structural feature in L-trans- 
pyrrolidine-2&dicarboxylate does not have a similar. 
inactivating, effect. 
High-affinity uptake of L-glutamate has boen studied 
in blood platelets [46,4?] which are known to have se- 
veral distinct neuronal characteristics (481 and a similar 
system has been detected in brain capillaries [49]. How- 
ever, the presence of a Na’-dependent high affinity up- 
take of L-glutamate in fibroblasts and the potential ubi- 
quity of such cells in vivo would seem to indicate that 
a type of glutamate uptake usually found only in ner- 
vous tissue may sometimes appear in structures which 
are in no way reidisd tither to the central or peripheral 
nervous system. The present findings may thus help to 
explain the recent failure of an antibody raised against 
thr glycoprotein thought to form the glutamate trans- 
porter [50] to specifically label the neuronal structures 
known to be glutamatergic in the rat brain [51]. Also. 
the existence of fibroblast-located glutamate uptake 
may have important implications for the experiments in 
which Xenopus laevis oocyte system is utilized to study 
the characteristics of glutamate 1. .,l.sporter expreAJzd 
from fragments of mRNA obtained in early postnatal 
tissues [52]. 
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